PA
GFS icon

PharVision Advisers’s GlobalFoundries GFS Stock Holding History

PharVision Advisers’s Portfolio GFS Stock Details GFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,623
Closed -$253K – 711
2025
Q2 		$253K Buy
+6,623
New +$240K 0.36% 133

Other funds holding GFS

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PharVision Advisers's GFS Position: Q3 2025 in Review

PharVision Advisers sold out of GlobalFoundries (GFS) in Q3 2025, closing a stake of 6,623 shares — an estimated $253K sold.

PharVision Advisers first reported a position in GFS in Q2 2025 and held it in 1 quarter. The position peaked at $253K in Q2 2025. 287 funds tracked by Wall St. Rank hold GFS as of Q3 2025.

  • PharVision Advisers reported no remaining GlobalFoundries position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 6,623 GlobalFoundries shares in Q3 2025, an estimated $253K.
  • PharVision Advisers first reported a position in GlobalFoundries in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's GlobalFoundries position peaked at $253K in Q2 2025.
  • 287 funds tracked by Wall St. Rank held GlobalFoundries as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.